pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic.

Vaccine 105

Vaccine Vaccination Life Science Regulation 105

BioTech 365

APRIL 15, 2021

Global Vaccine Storage and Packaging Market is Estimated to Account for US$ 15 Bn by End of 2027, Says Coherent Market Insights (CMI) Global Vaccine Storage and Packaging Market is Estimated to Account for US$ 15 Bn by End of 2027, Says … Continue reading →

Packaging 40

Packaging Packaging Marketing Vaccine 40

BioTech 365

JANUARY 13, 2022

COVID-19 Vaccine Packaging and Delivery Devices Market Share, Trends, Industry Analysis and Segment Forecasts 2021 – 2028 – ResearchAndMarkets.com COVID-19 Vaccine Packaging and Delivery Devices Market Share, Trends, Industry Analysis and Segment Forecasts 2021 – 2028 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The (..)

Packaging 40

Packaging Packaging Vaccine Vaccination 40

BioTech 365

NOVEMBER 26, 2020

Global Pharmaceutical Packaging Equipment Market 2020-2027: Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand – ResearchAndMarkets.com Global Pharmaceutical Packaging Equipment Market 2020-2027: Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand – ResearchAndMarkets.com DUBLIN–(BUSINESS (..)

Packaging 40

Packaging Packaging Vaccine Vaccination 40

Pharma in Brief

DECEMBER 3, 2020

Any authorization for drugs, vaccines, and medical devices issued pursuant to the interim orders are also set to terminate when the respective interim order expires or is withdrawn. Drugs and Vaccines. require market authorization holders to meet post-marketing regulatory requirements; and.

Vaccine 98

Vaccine Vaccination Drugs Manufacturing 98

XTalks

OCTOBER 25, 2023

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. FluMist has been in the market since 2003 and is the only intranasal spray vaccine option against flu.

Vaccine 59

Vaccine Vaccination Sales Pharmacy 59

The Pharma Data

MAY 3, 2021

The European Medicines Agency (EMA) is evaluating an application submitted by Pfizer and BioNTech for use of their COVID-19 vaccine in children aged 12 to 15 years. . The vaccine has been authorized by the EU for use in people 16 years and up since December 2020. . Pfizer also shared antibody responses from the younger age group.

Vaccine 52

Vaccine Vaccination Antibody RNA 52

Pfizer

APRIL 14, 2023

Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines kimkevin Fri, 04/14/2023 - 15:38 Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines Friday, January 22, 2021 - 11:21am Share We have crossed another milestone in the fight against COVID-19.

Vaccine 52

Vaccine Vaccination Development Manufacturing 52

The Pharma Data

NOVEMBER 22, 2020

As the Pfizer and BioNTech COVID-19 vaccine goes to regulators and the Moderna vaccine approaches the end of its Phase III trials, AstraZeneca and the University of Oxford announced high-level results from an interim analysis of their COVID-19 vaccine, AZD1222. The combined analysis showed average efficacy of 70%.

Vaccine 52

Vaccine Vaccination Protein Genetics 52

The Pharma Data

OCTOBER 30, 2020

Takeda and Moderna join forces to expand Covid-19 vaccine supply in Japan. A three-way agreement between Takeda , Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW) plans to bring mRNA-1273, Moderna’s Covid-19 vaccine candidate, to Japan. Source link.

FDA Approval 52

FDA Approval Vaccine Vaccination Clinical Trials 52

Roots Analysis

OCTOBER 30, 2023

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

RNA 40

RNA Vaccine Vaccination Development 40

XTalks

DECEMBER 29, 2021

Bayer has announced that all of its products will have 100 percent green packaging by 2030. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or reusable in less than ten years’ time.

Packaging 59

Packaging Packaging Production Allergies 59

Roots Analysis

FEBRUARY 1, 2024

Further, the cold chain storage process involves the cold chain storage, cold chain transportation, and monitoring temperature controlled packaging products. Therefore, the pharmaceutical, biotech, food and chemical industries usually rely on cold chain packaging for the transportation of their products.

Packaging 40

Packaging Packaging Containment Production 40

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Gene Therapy 162

Gene Therapy Packaging Packaging Contract Packaging 162

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The post 7 Problems with Using Borosilicate Glass to Package Drugs appeared first on Pharma Mirror Magazine.

Packaging 130

Packaging Packaging Drugs Clinical Trials 130

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally.

Contamination 130

Contamination Packaging Packaging Manufacturing 130

Pharmaceutical Technology

DECEMBER 8, 2022

Forward-thinking suppliers, including packaging component providers, are also looking at how they can improve their processes through digital technologies. Tom Lenaerts is head of global process engineering for Datwyler, a leading supplier of parenteral packaging components such as stoppers and plungers. By Datwyler. United Kingdom.

Manufacturing 246

Manufacturing Packaging Packaging Production 246

Pharmaceutical Technology

NOVEMBER 30, 2022

These contracts involve the manufacturing of biological and small molecule active pharmaceutical ingredients (APIs), parenteral manufacturing and packaging, and other manufacturing-related tasks. The EMA had provided a positive opinion for this marketing authorization back in July. Regulatory decisions come in. NICE decisions.

Manufacturing 130

Manufacturing Packaging Packaging Drugs 130

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.

Genome 244

Genome Genomics Medicine Gene Therapy 244

Pharmaceutical Technology

MARCH 21, 2023

Based on the individual contract, these CMOs manufacture small molecules or biological active pharmaceutical ingredients (APIs), as well as packaging material, and are charged with other related functions. Sharp Packaging Services is producing the solid dose of the drug and packaging it.

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

Pharmaceutical Technology

AUGUST 31, 2022

The COVID-19 pandemic and the resulting demand that it put on the pharmaceutical industry to supply vaccines, highlighted how the supply chain has several potential points of failure, making it much harder to control and predict. According to Corey Walker, CEO of ILC Dover: “When we identify constraints in the markets we serve – we respond.

Packaging 130

Packaging Packaging Production Containment 130

Pharmaceutical Technology

MARCH 22, 2023

The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says. Among other things, supply chain optimisation, maintaining access to affordable vaccines, and supporting innovation for unmet clinical needs will be the discussion topics, she adds.

Production 263

Production Manufacturing Drugs Generic Drugs 263

Pharmaceutical Technology

NOVEMBER 22, 2022

Despite China producing a significant proportion of the world’s API supply (mostly small molecule), it manufactures relatively few biosimilar and innovator drugs and no cell and gene therapies for the western markets of Europe and the US despite investments and an increasing number of startups to improve innovative manufacture.

Manufacturing 162

Manufacturing Gene Therapy Gene Contract Manufacturing 162

pharmaphorum

JANUARY 27, 2023

Even if underlying inflation levels ease off compared to last year – and there are some encouraging initial market signals – it’s important to focus on the areas that actually drive production costs for the industry. The same goes for many commodities used in the production process for key medicines, from solvents through to packaging.

Medicine 105

Medicine Production Marketing Packaging 105

World of DTC Marketing

APRIL 5, 2021

“Every day, I wonder if I’m going to call into my manager’s office and offered a package because I earn so much,” she told me. Some employees talk about how proud they are that their company has developed a vaccine for COVID-19. Healthcare in the US has become a big business with big profits.

Nurses 188

Nurses Packaging Packaging Pharmacy 188

pharmaphorum

MAY 27, 2022

Not only can conducting clinical research in representative patient groups help actively address unmet areas of medical need for underrepresented populations, but it has the secondary effect of helping companies gain a competitive advantage in an evolving market.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

World of DTC Marketing

JULY 20, 2022

“This is PPfizer’sfourth hike on the cancer drug during the Covid-19 pandemic—even as the company enjoys record-shattering profits from its vaccine,” “the analysis notes. Pfizer, for instance, hiked the cost of its leukemia medication Besponsa again this month, bringing its per-vial price tag to $21,056.

Packaging 183

Packaging Packaging Drugs Vaccination 183

The Pharma Data

JANUARY 6, 2021

6 January 2021 — AstraZeneca’s COVID-19 vaccine has been granted emergency use authorisation in India as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco for the active immunisation of adults.

Vaccine 52

Vaccine Vaccination Clinical Trials Clinical Trials 52

The Pharma Data

MARCH 25, 2021

European Medicines Agency to Conduct First-Ever Parallel Assessment of a Medicinal Product, Takeda’s Dengue Vaccine Candidate (TAK-003), for use in the EU; Countries Outside of the EU through the EU-M4all (Previously Article 58) Procedure.

Vaccine 52

Vaccine Vaccination Medicine Trials 52

XTalks

OCTOBER 26, 2020

Related: Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula? She said that’s why it’s “so important that we educate the market with campaigns like the ones we’ve launched.” Provention will conclude the filing upon submission of its manufacturing package this quarter. TID affects 1.6

Insulin 98

Insulin Packaging Packaging Doctors 98

pharmaphorum

NOVEMBER 27, 2022

This means batch sizes can be tailored to daily demands rather than market forecasts. It’s imperative that all suppliers and distributors know if disruption is likely to occur, whether that be concerning incoming raw materials or outgoing packaged drugs. Better communication with traceable data.

Production 105

Production Manufacturing Drugs Marketing 105

The Pharma Data

NOVEMBER 30, 2020

(Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis.

Vaccine 52

Vaccine Vaccination Medicine Clinical Trials 52

pharmaphorum

JANUARY 17, 2022

As such, the UK will no longer be part of the EU free market. Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym. Market Access. SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. Supply Chain Development – Brexit.

Packaging 52

Packaging Packaging Marketing Regulation 52

World of DTC Marketing

MARCH 17, 2021

The rapid rollout of Covid-19 vaccines has made household names of Pfizer and AstraZeneca, and the whole industry is winning praise for co-operation” However, the bump in reputation will be short-lived because companies need to earn the public’s trust every day, and pharma is already damaging their perception with people.

Drugs 186

Drugs Vaccination Vaccine Sales 186

Pharmaceutical Technology

MARCH 10, 2023

Pharmaceutical and biotechnology industries widely use freeze-drying systems to protect vaccines, antibodies, antibiotics such as penicillin, blood plasma, proteins, enzymes, hormones, viruses, and bacteria from heat and minimise their biological activity. The process eliminates the disadvantages of conventional drying methods or freezing.

Manufacturing 147

Manufacturing Production Containment Antibody 147

Pharmaceutical Technology

JANUARY 12, 2023

PM: Lyophilization is widely used in the pharmaceutical and biotech industry for small molecule drug products, vaccines, antibodies, and other biological material. That would not allow sufficient time to manufacture, package and distribute before half of the content was degraded. A great example is aspirin.

Production 130

Production Contamination Development Manufacturing 130

Pharmaceutical Technology

DECEMBER 15, 2022

The Singapore Government has launched Biologics Pharma Innovation Programme Singapore (BioPIPS), which aims to increase the country’s manufacturing capacity for biologics, including recombinant proteins and vaccines. The organizations plan to use data analytics to improve manufacturing processes. Additionally, Merck & Co.

Manufacturing 264

Manufacturing Vaccination Vaccine Production 264